PPP1R15A and neoplasm: ICD inducers, such as anthracyclines, PP1/GADD34 inhibitors, cardiac glycosides, oxaliplatin, bleomycin, cyclophosphamide, and shikonin, have been used to induce ICD and inhibit tumor growth [10,11].